Name: Influenza Vaccines Market Size, Growth Opportunities, Trends Analysis, Statistics &amp; Industry Forecast Report, 2020-2027
SKU: HM01A-00-0617
Availability: InStock

Influenza Vaccines Market Size, Growth Opportunities, Trends Analysis, Statistics & Industry Forecast Report, 2020-2027

Influenza Vaccines Market Size, Growth & Industry Research Report by Vaccine Type (Quadrivalent, Trivalent), by Route of Administration (Intramuscular, Intravenous, Others), and by Geography – Global Forecast till 2027

Report Description Table Of Content Sample Request Request For Customization

1. Executive Summary

2. Introduction

2.1. Study Objectives

2.2. Scope of the study

2.2.1. Market Covered

2.2.2. Geographical Coverage

2.2.3. Forecast Data

2.3. Research Methodology

3. Global Influenza Vaccines Market Overview

3.1. Introduction

3.2. Market Segmentation

3.2.1 By Vaccine Type

3.2.2 By Route of Administration

3.3. Value Chain Analysis

3.4. Market Drivers

3.5. Market Restraints/Inhibitors

3.6. Market Attractiveness and Technology Trend

4. Global Influenza Vaccines Market Outlook to 2025

4.1 By Vaccine Type

4.1.1 Quadrivalent Vaccines

4.1.2 Trivalent Vaccines

4.2 By Route of Administration

4.2.1 Intramuscular

4.2.2 Intravenous

4.2.3 Other

5. Global Influenza Vaccines: Pipeline Analysis

5.1. By Phase

6. Global Influenza Vaccines Market by Geography

6.1. North America

6.1.1 By Vaccine type

6.1.2 By Route of Administration

6.2. Europe

6.2.1 By Vaccine type

6.2.2 By Route of Administration

6.3. Asia-Pacific

6.3.1. By Vaccine Type

6.3.2. By Route of Administration

6.4. Rest of the World

6.4.1 By Vaccine Type

7. Global Influenza Vaccines Market by Country

7.1. United States

7.2. United Kingdom

7.3. China

7.4. India

7.5. Brazil

8. Competitive Landscape

8.1. Major Players Market Share Analysis

8.2. Porter’s Five Forces Analysis

9. Company Profiles

9.1. Sanofi

9.1.1. Overview

9.1.2. Financial analysis

9.1.3. Recent Developments

9.2. GlaxoSmithKline plc

9.2.1. Overview

9.2.2. Financial analysis

9.2.3. Recent Developments

9.3. CSL Limited

9.3.1 Overview

9.3.2. Financial analysis

9.3.3. Recent Developments

9.4. AstraZeneca

9.4.1. Overview

9.4.2. Financial analysis

9.4.3. Recent Developments

9.5. Sinovac Biotech Ltd.

9.5.1. Overview

9.5.2. Financial analysis

9.5.3. Recent Developments

9.6. Sarepta Therapeutics, Inc.

9.6.1. Overview

9.6.2. Financial analysis

9.6.3. Recent Developments

9.7. Novavax, Inc.

9.7.1. Overview

9.7.2. Financial analysis

9.8. Abbott

9.8.1. Overview

9.8.2. Financial analysis

9.9. Inovio Pharmaceuticals, Inc.

9.9.1. Overview

9.9.2. Financial analysis

9.9.3. Recent Developments

9.10. Janssen Global Services, LLC

9.10.1. Overview

9.10.2. Financial analysis

9.10.3. Recent Developments

10. Appendix

download free sample now

Published Date: Feb-2020
Report Format: Excel/PPT
Report Code: HM01A-00-0617

Get Free 25% Customization in this Report

Licensing Options
Single-User License:
The report is used by the purchaser (One Individual) only

Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only

Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only